NCT02332577 - Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia | Biotech Hunter

Enrollment

161

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 20, 2023

Study Completion Date

February 20, 2023

Conditions

Pneumonia

Interventions

DRUG

PRISTINAMYCIN XRP7263

Pharmaceutical form:tablet 500 mg Route of administration: oral

DRUG

Amoxicillin

Pharmaceutical form:capsule 500 mg Route of administration: oral

DRUG

Amoxicillin Placebo

Pharmaceutical form: capsule Route of administration: oral

DRUG

PRISTINAMYCIN Placebo

Pharmaceutical form:Tablet Route of administration: Oral

Trial Locations (19)

5000

Investigational Site Number :788007, Monastir

Investigational Site Number :788011, Monastir

37000

Investigational Site Number :250034, Tours

37420

Investigational Site Number :250029, Avoine

37520

Investigational Site Number :250032, La Riche

38043

Investigational Site Number :250010, Grenoble

42277

Investigational Site Number :250001, Saint-Priest-en-Jarez

44093

Investigational Site Number :250023, Nantes

49500

Investigational Site Number :250031, Segré

74374

Investigational Site Number :250004, Pringy

75010

Investigational Site Number :250022, Paris

92701

Investigational Site Number :250015, Colombes

98012

Investigational Site Number :250054, Monaco Cedex

Unknown

Investigational Site Number :788001, Aryanah

Investigational Site Number :788002, Aryanah

Investigational Site Number :788004, Aryanah

Investigational Site Number :788005, Aryanah

Investigational Site Number :788014, La Marsa

Investigational Site Number :788009, Sfax